{"id":"https://openalex.org/W4416630063","doi":"https://doi.org/10.1158/1078-0432.30709895","title":"Supplementary Table S2 from Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.","display_name":"Supplementary Table S2 from Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416630063","doi":"https://doi.org/10.1158/1078-0432.30709895"},"language":null,"primary_location":{"id":"doi:10.1158/1078-0432.30709895","doi":"https://doi.org/10.1158/1078-0432.30709895","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709895","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Safety_Immunologic_and_Clinical_Activity_of_Durvalumab_in_Combination_with_Olaparib_or_Cediranib_in_Advanced_Leiomyosarcoma_Results_of_the_DAPPER_Clinical_Trial_/30709895/1/files/59834729.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Safety_Immunologic_and_Clinical_Activity_of_Durvalumab_in_Combination_with_Olaparib_or_Cediranib_in_Advanced_Leiomyosarcoma_Results_of_the_DAPPER_Clinical_Trial_/30709895/1/files/59834729.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038403736","display_name":"Abdulazeez Salawu","orcid":"https://orcid.org/0000-0002-4420-0958","observed_orcids":["https://orcid.org/0000-0002-4420-0958"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdulazeez Salawu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4420-0958","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036258389","display_name":"Ben X. Wang","orcid":"https://orcid.org/0000-0003-1842-7371","observed_orcids":["https://orcid.org/0000-0003-1842-7371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ben X. Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1842-7371","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064595778","display_name":"Ming Han","orcid":"https://orcid.org/0000-0002-0136-2412","observed_orcids":["https://orcid.org/0000-0002-0136-2412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Han","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0136-2412","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088185146","display_name":"Caryn Geady","orcid":"https://orcid.org/0000-0002-0637-0710","observed_orcids":["https://orcid.org/0000-0002-0637-0710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caryn Geady","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0637-0710","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018635701","display_name":"Alya Heirali","orcid":"https://orcid.org/0000-0001-5259-0434","observed_orcids":["https://orcid.org/0000-0001-5259-0434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alya Heirali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5259-0434","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040964442","display_name":"Hal K. Berman","orcid":"https://orcid.org/0000-0001-7524-7911","observed_orcids":["https://orcid.org/0000-0001-7524-7911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hal K. Berman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7524-7911","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064476636","display_name":"Thomas Daniel Pfister","orcid":"https://orcid.org/0009-0006-9766-2984","observed_orcids":["https://orcid.org/0009-0006-9766-2984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas D. Pfister","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-9766-2984","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013892733","display_name":"Alberto Hernando\u2010Calvo","orcid":"https://orcid.org/0000-0002-1692-1125","observed_orcids":["https://orcid.org/0000-0002-1692-1125"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto Hernando-Calvo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1692-1125","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050019367","display_name":"Esmail Mutahar Al-Ezzi","orcid":"https://orcid.org/0000-0002-9012-9187","observed_orcids":["https://orcid.org/0000-0002-9012-9187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esmail Mutahar Al-Ezzi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9012-9187","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078517579","display_name":"Lee-Anne Stayner","orcid":"https://orcid.org/0009-0007-1488-9970","observed_orcids":["https://orcid.org/0009-0007-1488-9970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee-Anne Stayner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-1488-9970","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038846734","display_name":"Abha A. Gupta","orcid":"https://orcid.org/0000-0002-0825-5070","observed_orcids":["https://orcid.org/0000-0002-0825-5070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abha A. Gupta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0825-5070","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023074071","display_name":"Olubukola Ayodele","orcid":"https://orcid.org/0000-0003-3809-528X","observed_orcids":["https://orcid.org/0000-0003-3809-528X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olubukola Ayodele","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3809-528X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056727641","display_name":"Bernard Lam","orcid":"https://orcid.org/0000-0002-6437-6491","observed_orcids":["https://orcid.org/0000-0002-6437-6491"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernard Lam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6437-6491","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022267545","display_name":"Aaron Richard Hansen","orcid":"https://orcid.org/0000-0002-2363-8707","observed_orcids":["https://orcid.org/0000-0002-2363-8707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron R. Hansen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2363-8707","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088186975","display_name":"Anna Spreafico","orcid":"https://orcid.org/0000-0002-3034-3042","observed_orcids":["https://orcid.org/0000-0002-3034-3042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Spreafico","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3034-3042","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe L. Bedard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6771-2999","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008158683","display_name":"Marcus Otho Butler","orcid":"https://orcid.org/0000-0002-9840-7057","observed_orcids":["https://orcid.org/0000-0002-9840-7057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcus O. Butler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9840-7057","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066208725","display_name":"Lisa M. Avery","orcid":"https://orcid.org/0000-0002-8431-5143","observed_orcids":["https://orcid.org/0000-0002-8431-5143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Avery","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8431-5143","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021953098","display_name":"Bryan A. Coburn","orcid":"https://orcid.org/0000-0003-0150-4510","observed_orcids":["https://orcid.org/0000-0003-0150-4510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan Coburn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0150-4510","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010487226","display_name":"Benjamin Haibe\u2010Kains","orcid":"https://orcid.org/0000-0002-7684-0079","observed_orcids":["https://orcid.org/0000-0002-7684-0079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Haibe-Kains","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7684-0079","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000204204","display_name":"Lillian L. Siu","orcid":"https://orcid.org/0000-0002-3500-0540","observed_orcids":["https://orcid.org/0000-0002-3500-0540"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lillian L. Siu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3500-0540","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059182981","display_name":"Albiruni R. Abdul Razak","orcid":"https://orcid.org/0000-0001-7657-9950","observed_orcids":["https://orcid.org/0000-0001-7657-9950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albiruni R. Abdul Razak","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7657-9950","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.29589998722076416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9729999899864197},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.984000027179718},{"id":"https://openalex.org/keywords/cediranib","display_name":"cediranib","score":0.996999979019165},{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.9509999752044678},{"id":"https://openalex.org/keywords/best-overall-response","display_name":"best overall response","score":0.878000020980835},{"id":"https://openalex.org/keywords/irecist","display_name":"iRECIST","score":0.8600000143051147},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9703999757766724},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.7522000074386597},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6198999881744385},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5781000256538391},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4359000027179718},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3937999904155731},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34790000319480896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2621000111103058},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25209999084472656},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.219200000166893}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709895","doi":"https://doi.org/10.1158/1078-0432.30709895","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709895","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Safety_Immunologic_and_Clinical_Activity_of_Durvalumab_in_Combination_with_Olaparib_or_Cediranib_in_Advanced_Leiomyosarcoma_Results_of_the_DAPPER_Clinical_Trial_/30709895/1/files/59834729.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709895","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Safety_Immunologic_and_Clinical_Activity_of_Durvalumab_in_Combination_with_Olaparib_or_Cediranib_in_Advanced_Leiomyosarcoma_Results_of_the_DAPPER_Clinical_Trial_/30709895","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709895","doi":"https://doi.org/10.1158/1078-0432.30709895","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709895","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Safety_Immunologic_and_Clinical_Activity_of_Durvalumab_in_Combination_with_Olaparib_or_Cediranib_in_Advanced_Leiomyosarcoma_Results_of_the_DAPPER_Clinical_Trial_/30709895/1/files/59834729.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416630063.pdf","grobid_xml":"https://content.openalex.org/works/W4416630063.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Table":[0],"S2:":[1],"Best":[2],"overall":[3],"responses":[4],"(iRECIST)":[5],"of":[6],"leiomyosarcoma":[7],"patients":[8],"on":[9],"the":[10],"DAPPER":[11],"study":[12]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-11-25T00:00:00"}